(CHE) Chemed - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16359R1032

CHE EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CHE over the last 5 years for every Quarter.

CHE Revenue

This chart shows the Revenue of CHE over the last 5 years for every Quarter.

CHE: Hospice Care, Plumbing Services, Drain Cleaning, Water Restoration

Chemed Corporation is a multifaceted healthcare services provider and plumbing specialist, operating primarily in the United States through its VITAS and Roto-Rooter segments. The VITAS segment delivers hospice and palliative care services, leveraging a network of healthcare professionals to provide direct medical services, spiritual support, and emotional counseling to patients and their families. In contrast, the Roto-Rooter segment focuses on plumbing, drain cleaning, and related services for residential and commercial clients, utilizing a mix of company-owned branches, independent contractors, and franchisees. This diversified business model allows Chemed Corporation to maintain a strong presence in both the healthcare and plumbing services markets.

From a business perspective, Chemed Corporations operations are characterized by a high degree of specialization and a commitment to delivering high-quality services. The companys hospice and palliative care services are designed to provide comfort and support to patients with serious illnesses, while its plumbing services aim to address a range of customer needs, from routine maintenance to emergency repairs. By maintaining a strong network of professionals and a robust service infrastructure, Chemed Corporation is well-positioned to capitalize on growth opportunities in both its core markets.

Analyzing the available and , we can observe that Chemed Corporations stock has demonstrated a relatively stable trading pattern, with a current price of $560.78 and a 20-day SMA of $569.16. The stocks 52-week high and low are $618.67 and $516.52, respectively, indicating a moderate level of price volatility. With a market capitalization of $8.315 billion and a forward P/E ratio of 22.57, Chemed Corporation appears to be a reasonably valued company with a strong financial profile, as evidenced by its RoE of 26.03%. Based on these metrics, a potential forecast is that the stock may experience a moderate increase in value over the next quarter, driven by the companys continued growth and profitability in its core markets. Specifically, if the current trends in continue, we can expect the stock to potentially reach $590 within the next 3-6 months, assuming a continued stable financial performance and a moderate expansion in its business segments.

In conclusion, Chemed Corporations diversified business model, strong financial profile, and growth prospects make it an attractive investment opportunity for investors seeking exposure to the healthcare services and plumbing industries. By closely monitoring the companys financial performance and market trends, investors can make informed decisions about their investment in Chemed Corporation.

Additional Sources for CHE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CHE Stock Overview

Market Cap in USD 8,315m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 1973-05-03

CHE Stock Ratings

Growth Rating 36.7
Fundamental 79.3
Dividend Rating 53.5
Rel. Strength 9.96
Analysts 4.67 of 5
Fair Price Momentum 489.37 USD
Fair Price DCF 461.99 USD

CHE Dividends

Dividend Yield 12m 0.36%
Yield on Cost 5y 0.45%
Annual Growth 5y 6.40%
Payout Consistency 97.0%
Payout Ratio 8.5%

CHE Growth Ratios

Growth Correlation 3m -80%
Growth Correlation 12m 20.9%
Growth Correlation 5y 78.5%
CAGR 5y 4.12%
CAGR/Max DD 5y 0.16
Sharpe Ratio 12m 0.95
Alpha -2.98
Beta 0.174
Volatility 21.38%
Current Volume 165.1k
Average Volume 20d 109.5k
What is the price of CHE shares?
As of June 18, 2025, the stock is trading at USD 549.65 with a total of 165,108 shares traded.
Over the past week, the price has changed by -0.76%, over one month by -4.83%, over three months by -9.53% and over the past year by +2.33%.
Is Chemed a good stock to buy?
Yes, based on ValueRay´s Fundamental Analyses, Chemed (NYSE:CHE) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 79.26 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHE is around 489.37 USD . This means that CHE is currently overvalued and has a potential downside of -10.97%.
Is CHE a buy, sell or hold?
Chemed has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy CHE.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for CHE share price target?
According to our own proprietary Forecast Model, CHE Chemed will be worth about 530.7 in June 2026. The stock is currently trading at 549.65. This means that the stock has a potential downside of -3.44%.
Issuer Target Up/Down from current
Wallstreet Target Price 677.3 23.2%
Analysts Target Price 677.3 23.2%
ValueRay Target Price 530.7 -3.4%